A recent study demonstrated that resveratrol could lower oxidative stress and cardiac ischemia/reperfusion injury via AMPK/p38/Nrf2 pathway activation [60], but its specific role in fructose-induced NASH models has not been fully elucidated. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.